Screw worm infectious disease

disease
On this page

Also known as Cochliomyia hominivorax caused disease or disorderCochliomyia hominivorax disease or disorderCochliomyia hominivorax infectious diseaseinfection, screw worminfections, screw wormscrew worm infections

Summary

Screw worm infectious disease (MONDO:0005954) is a disease. A subtype of myiasis — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

FieldValue
Canonical namescrew worm infectious disease
Mondo IDMONDO:0005954
MeSHD012610
DOIDDOID:12927
GARD0024260
Is cancer (heuristic)no

Also known as: Cochliomyia hominivorax caused disease or disorder · Cochliomyia hominivorax disease or disorder · Cochliomyia hominivorax infectious disease · infection, screw worm · infections, screw worm · screw worm infections

Disease family

Classification path: disease › human disease › disease by etiologic mechanism › disease of primarily extrinsic mechanism › infectious diseaseparasitic infectious disease › parasitic skin disorder › parasitic ectoparasitic infectious disease › myiasis › screw worm infectious disease

Related subtypes (3): hypodermyiasis, cavitary myiasis, cutaneous myiasis

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.